StreetInsider.com News Articles

BofA Securities Reiterates Buy Rating on Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF)

Fri, 04 Sep 2026 06:07:18 -0400

BofA Securities reiterated a Buy rating and GBP18.00 price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF).

BofA Securities Reiterates Buy Rating on Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF)

Fri, 04 Sep 2026 06:07:18 -0400

BofA Securities reiterated a Buy rating and GBP18.00 price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF).

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP2,025 at Jefferies

Tue, 25 Aug 2026 06:02:07 -0400

Jefferies analyst James Vane-Tempest raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP2,025.00 (from GBP1,870.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP2,025 at Jefferies

Tue, 25 Aug 2026 06:02:07 -0400

Jefferies analyst James Vane-Tempest raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP2,025.00 (from GBP1,870.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP2,025 at Jefferies

Tue, 25 Aug 2026 06:02:07 -0400

Jefferies analyst James Vane-Tempest raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP2,025.00 (from GBP1,870.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP2,025 at Jefferies

Tue, 25 Aug 2026 06:02:07 -0400

Jefferies analyst James Vane-Tempest raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP2,025.00 (from GBP1,870.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP18.70 at Citi

Wed, 12 Aug 2026 04:37:24 -0400

Citi analyst Giang Nguyen raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP18.70 (from GBP17.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP18.70 at Citi

Wed, 12 Aug 2026 04:37:24 -0400

Citi analyst Giang Nguyen raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP18.70 (from GBP17.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP18.70 at Citi

Wed, 12 Aug 2026 04:37:24 -0400

Citi analyst Giang Nguyen raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP18.70 (from GBP17.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP18.70 at Citi

Wed, 12 Aug 2026 04:37:24 -0400

Citi analyst Giang Nguyen raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP18.70 (from GBP17.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP21 at Berenberg

Tue, 11 Aug 2026 04:50:08 -0400

Berenberg analyst Victoria Lambert raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP21.00 (from GBP18.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP21 at Berenberg

Tue, 11 Aug 2026 04:50:08 -0400

Berenberg analyst Victoria Lambert raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP21.00 (from GBP18.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP21 at Berenberg

Tue, 11 Aug 2026 04:50:08 -0400

Berenberg analyst Victoria Lambert raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP21.00 (from GBP18.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP21 at Berenberg

Tue, 11 Aug 2026 04:50:08 -0400

Berenberg analyst Victoria Lambert raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP21.00 (from GBP18.00) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP20.50 at Deutsche Bank

Mon, 10 Aug 2026 04:32:36 -0400

Deutsche Bank analyst Kane Slutzkin raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.50 (from GBP19.50) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP20.50 at Deutsche Bank

Mon, 10 Aug 2026 04:32:36 -0400

Deutsche Bank analyst Kane Slutzkin raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.50 (from GBP19.50) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP20.50 at Deutsche Bank

Mon, 10 Aug 2026 04:32:36 -0400

Deutsche Bank analyst Kane Slutzkin raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.50 (from GBP19.50) while maintaining a Buy rating.

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP20.50 at Deutsche Bank

Mon, 10 Aug 2026 04:32:36 -0400

Deutsche Bank analyst Kane Slutzkin raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.50 (from GBP19.50) while maintaining a Buy rating.

Citi Starts Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) at Buy

Thu, 16 Jul 2026 01:53:48 -0400

Citi analyst Giang Nguyen initiates coverage on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) with a Buy rating and a price target of GBP17.00.

Citi Starts Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) at Buy

Thu, 16 Jul 2026 01:53:48 -0400

Citi analyst Giang Nguyen initiates coverage on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) with a Buy rating and a price target of GBP17.00.

Citi Starts Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) at Buy

Thu, 16 Jul 2026 01:53:48 -0400

Citi analyst Giang Nguyen initiates coverage on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) with a Buy rating and a price target of GBP17.00.

Citi Starts Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) at Buy

Thu, 16 Jul 2026 01:53:48 -0400

Citi analyst Giang Nguyen initiates coverage on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) with a Buy rating and a price target of GBP17.00.

Barclays Reiterates Underweight Rating on Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF)

Tue, 23 Jun 2026 02:42:54 -0400

Barclays analyst James Gordon reiterated an Underweight rating and GBP13.50 price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF).

Barclays Reiterates Underweight Rating on Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF)

Tue, 23 Jun 2026 02:42:54 -0400

Barclays analyst James Gordon reiterated an Underweight rating and GBP13.50 price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF).

Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP1,870 at Jefferies

Tue, 05 May 2026 05:04:24 -0400

Jefferies analyst James Vane-Tempest raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP1,870.00 (from GBP1,850.00) while maintaining a Buy rating.